CD14 (C-159→T) Polymorphism and Levels of C-reactive Protein
Authors:
J. A. Hubáček 2; P. Stávek 2; J. Piťha 2; Z. Škodová 1; R. Poledne 2
Authors‘ workplace:
Laboratoř pro výzkum aterosklerózy IKEM, Praha 2Centrum experimentálního výzkumu chorob srdce a cév, Praha
1
Published in:
Čas. Lék. čes. 2003; : 174-176
Category:
Overview
Background.
High plasma levels of C-reactive protein (involved in unspecific host defence) have been described asindependent risk factor of atherosclerosis. The possible association has been analysed between the CD14 C-159→Tpolymorphism and plasma level of CRP.Methods and Results.With the PCR and subsequent restriction analysis we have evaluated C-159→T polymorphismin the CD14 gene of 166 representatively selected male Caucasians with known plasma level of CRP. The CRP wasmeasured immunologically. A significantly higher (p 2.19 mg/l (31.9 %, 15 out of 47) has been detected when comparedto the group with plasma level of CRP lower than 2.18 mg/l (11.9 %, 5 out of 42).Conclusions. CD14 C-159→T polymorphism could be the first described genetic marker associated with plasmalevel of C-reactive protein.
Key words:
CD14 receptor, polymorphism, C-reactive protein.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- New Antiparasitic Drugs
- Renal Artery Embolism – Review of the Literature
- Hormones and Well Being of the Aging Men
- Fluorescence Cystoscopy with 5-Aminolevulinic Acid